Glimepiride Induced Insulin Secretion Will be Inhibited by Hypoglycemia.
Phase of Trial: Phase II
Latest Information Update: 21 Dec 2016
At a glance
- Drugs Glimepiride (Primary) ; Glibenclamide
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 12 Oct 2010 Planned end date changed from Aug 2009 to Dec 2010 as reported by ClinicalTrials.gov.
- 06 Mar 2008 New trial record.